Interestingly, only intra-prostatic MLL-tumors were able to increase BrdU-labeling in the lungs, suggesting that this could be an organ that responds selectively to aggressive prostate tumors—and importantly in a tumor size-dependent way. Here, KMT2A is linked to prostate neoplasm.